Lonza nominates Pearl Huang as independent board member
Bitget2026/09/30 05:01- Lonza nominated Pearl Huang as an independent board member, pending election at the May 2027 AGM.
- Huang would join the Strategy and Innovation Committee, plus the Remuneration Committee.
- She is an independent director at Waters Corp. and BB Biotech; previously held senior roles at Roche, GSK, Merck.
- Angelica Kohlmann, chair of the Strategy and Innovation Committee, will not stand for re-election at the 2027 AGM.
- Christoph Mäder, lead independent director and chair of the Remuneration Committee, will not stand for re-election at the 2027 AGM.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Metals Focus analysts remain bullish on gold: consolidating rather than turning bearish, with support near $4,000
Analysts from Metals Focus stated that the gold market is currently in a consolidation phase, rather than entering a bear market.
2-Yr Benchmark Govt Yields - Germany vs Other Nations
NVIDIA (NVDA.US) Leverages European Supercomputer to Achieve Record-Breaking Fault-Tolerant Simulation, Reducing Physical Qubits by 90%
Nvidia researchers have run what they call a record-breaking fault-tolerant quantum simulation on Jupiter, Europe's largest supercomputer.
Chilean old mine grades decline combined with adverse weather! BHP's Q3 copper production "plunges" but full-year guidance remains unchanged
Mining giant BHP stated that copper production has dropped significantly due to adverse weather conditions and declining ore grades at its major mine in Chile. However, the company is maintaining its full-year copper production guidance.
